Usana Health Sciences Stock Performance
| USNA Stock | USD 27.98 1.16 3.98% |
The entity owns a Beta (Systematic Risk) of 0.62, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, USANA Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding USANA Health is expected to be smaller as well. At this point, USANA Health Sciences has a negative expected return of -0.38%. Please make sure to validate USANA Health's potential upside, and the relationship between the jensen alpha and daily balance of power , to decide if USANA Health Sciences performance from the past will be repeated at future time.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days USANA Health Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return (3.98) | Five Day Return (15.42) | Year To Date Return (23.11) | Ten Year Return (43.84) | All Time Return 44.7 K |
Last Split Factor 2:1 | Last Split Date 2016-11-23 |
1 | USANA Appoints New Chief Scientific Officer | 01/22/2025 |
2 | Disposition of 1255 shares by Jim Brown of USANA Health at 30.65 subject to Rule 16b-3 | 02/07/2025 |
3 | Disposition of 1557 shares by David Mulham of USANA Health subject to Rule 16b-3 | 02/10/2025 |
4 | Disposition of 1456 shares by Paul Jones of USANA Health subject to Rule 16b-3 | 02/11/2025 |
5 | USNA or STVN Which Is the Better Value Stock Right Now | 02/14/2025 |
6 | USANA Health Sciences Surpasses Q4 Earnings and Revenue Estimates | 02/25/2025 |
7 | Usana Health Sciences Inc Q4 2024 Earnings Call Highlights Strong Sales Growth and ... | 02/27/2025 |
8 | USANA Exec. Chairman Kevin Guest Invites All to Celebrate Marchs Listening Awareness Month | 03/03/2025 |
9 | Insider Sell Jim Brown Sells 5,000 Shares of Usana Health Sciences Inc | 03/04/2025 |
10 | Disposition of 674 shares by Gilbert Fuller of USANA Health at 31.4398 subject to Rule 16b-3 | 03/06/2025 |
11 | Acquisition by Brent Neidig of 2220 shares of USANA Health subject to Rule 16b-3 | 03/07/2025 |
12 | Disposition of 500 shares by John Fleming of USANA Health at 33.2954 subject to Rule 16b-3 | 03/11/2025 |
13 | Disposition of 4743 shares by Brent Neidig of USANA Health at 32.3397 subject to Rule 16b-3 | 03/12/2025 |
14 | David Mulham Mulham Sells 3,234 Shares of USANA Health Sciences, Inc. Stock | 03/13/2025 |
| Begin Period Cash Flow | 333.2 M |
USANA |
USANA Health Relative Risk vs. Return Landscape
If you would invest 3,628 in USANA Health Sciences on December 17, 2024 and sell it today you would lose (830.00) from holding USANA Health Sciences or give up 22.88% of portfolio value over 90 days. USANA Health Sciences is currently does not generate positive expected returns and assumes 3.1367% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than USANA, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
USANA Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for USANA Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as USANA Health Sciences, and traders can use it to determine the average amount a USANA Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1218
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | USNA |
Estimated Market Risk
| 3.14 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.38 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average USANA Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of USANA Health by adding USANA Health to a well-diversified portfolio.
USANA Health Fundamentals Growth
USANA Stock prices reflect investors' perceptions of the future prospects and financial health of USANA Health, and USANA Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on USANA Stock performance.
| Return On Equity | 0.0776 | ||||
| Return On Asset | 0.06 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 398.12 M | ||||
| Shares Outstanding | 18.9 M | ||||
| Price To Earning | 8.70 X | ||||
| Price To Book | 1.04 X | ||||
| Price To Sales | 0.64 X | ||||
| Revenue | 854.5 M | ||||
| Gross Profit | 693.29 M | ||||
| EBITDA | 98.86 M | ||||
| Net Income | 42.06 M | ||||
| Cash And Equivalents | 246.88 M | ||||
| Cash Per Share | 12.82 X | ||||
| Total Debt | 23 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 2.71 X | ||||
| Book Value Per Share | 27.91 X | ||||
| Cash Flow From Operations | 60.99 M | ||||
| Earnings Per Share | 2.19 X | ||||
| Market Capitalization | 550.88 M | ||||
| Total Asset | 748.19 M | ||||
| Retained Earnings | 478.94 M | ||||
| Working Capital | 139.56 M | ||||
| Current Asset | 244.26 M | ||||
| Current Liabilities | 131.41 M | ||||
About USANA Health Performance
By analyzing USANA Health's fundamental ratios, stakeholders can gain valuable insights into USANA Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if USANA Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if USANA Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 126.30 | 103.74 | |
| Return On Tangible Assets | 0.13 | 0.12 | |
| Return On Capital Employed | 0.24 | 0.23 | |
| Return On Assets | 0.12 | 0.11 | |
| Return On Equity | 0.16 | 0.15 |
Things to note about USANA Health Sciences performance evaluation
Checking the ongoing alerts about USANA Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for USANA Health Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| USANA Health generated a negative expected return over the last 90 days | |
| USANA Health has high historical volatility and very poor performance | |
| USANA Health has a poor financial position based on the latest SEC disclosures | |
| About 59.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: David Mulham Mulham Sells 3,234 Shares of USANA Health Sciences, Inc. Stock |
- Analyzing USANA Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether USANA Health's stock is overvalued or undervalued compared to its peers.
- Examining USANA Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating USANA Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of USANA Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of USANA Health's stock. These opinions can provide insight into USANA Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for USANA Stock analysis
When running USANA Health's price analysis, check to measure USANA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy USANA Health is operating at the current time. Most of USANA Health's value examination focuses on studying past and present price action to predict the probability of USANA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move USANA Health's price. Additionally, you may evaluate how the addition of USANA Health to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets |